FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

318583001: Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2470232013 Co-prenozide 160mg/250mcg m/r tablet en Synonym Active Entire term case sensitive SNOMED CT core module
    2572069019 Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet (product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    2576042017 Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    2579359019 Oxprenolol+cyclopenthiazide 160mg/0.25mg m/r tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    46612101000001110 Co-prenozide 160mg/0.25mg modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Is a Product containing cyclopenthiazide and oxprenolol false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Is a Co-prenozide tablet false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has active ingredient Diuretic false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has active ingredient Oxprenolol false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Is a Product containing cyclopenthiazide and oxprenolol false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has active ingredient Cyclopenthiazide false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has active ingredient Oxprenolol hydrochloride false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has manufactured dose form Modified-release tablet false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has specific active ingredient Cyclopenthiazide false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has specific active ingredient Oxprenolol hydrochloride false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Is a Co-prenozide false Inferred relationship Existential restriction modifier
    Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-prenozide 160mg/0.25mg m/r tablet - product Is a False Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Inferred relationship Existential restriction modifier
    Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Is a False Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets 28 tablet Is pack of False Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Inferred relationship Existential restriction modifier
    Co-prenozide 160mg/0.25mg modified-release tablets 28 tablet Has VMP False Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start